This may represent an advantage for some WGD tumours, for example those acquiring BFB mediated amplifications of CCNE1, but appears to be a liability for those suffering the most severe chromothripsis events, which may contribute to increased immunogenicity or compromised metabolism, and are associated with longer overall patient survival (Fig. 6). Here, CCNE1 is linked to neoplasm.